{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:47:15Z","timestamp":1784774835829,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ejpb.2019.04.004","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T11:44:38Z","timestamp":1554205478000},"page":"197-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Targeted brain delivery of methotrexate by glutathione PEGylated liposomes: How can the formulation make a difference?"],"prefix":"10.1016","volume":"139","author":[{"given":"Yang","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter J.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.M.","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9181-1321","authenticated-orcid":false,"given":"Margareta","family":"Hammarlund-Udenaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2019.04.004_b0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","article-title":"Blood-brain barrier structure and function and the challenges for CNS drug delivery","volume":"36","author":"Abbott","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ejpb.2019.04.004_b0010","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1021\/mp300518e","article-title":"Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules","volume":"10","author":"Strazielle","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2019.04.004_b0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2016.02.026","article-title":"Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art","volume":"227","author":"Karim","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.04.004_b0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ddtec.2016.07.005","article-title":"Liposome technologies and drug delivery to the CNS","volume":"20","author":"Rip","year":"2016","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejpb.2019.04.004_b0025","series-title":"Drug Delivery to the Brain","first-page":"433","article-title":"Blood-to-brain drug delivery using nanocarriers","author":"Gaillard","year":"2014"},{"key":"10.1016\/j.ejpb.2019.04.004_b0030","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1172\/JCI114666","article-title":"Evidence for carrier-mediated transport of glutathione across the blood-brain barrier in the rat","volume":"85","author":"Kannan","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejpb.2019.04.004_b0035","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/bbrc.1994.1715","article-title":"Evidence for transcapillary transport of reduced glutathione in vascular perfused guinea-pig brain","volume":"201","author":"Zlokovic","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejpb.2019.04.004_b0040","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0006-8993(99)02184-8","article-title":"GSH transport in human cerebrovascular endothelial cells and human astrocytes: evidence for luminal localization of Na+-dependent GSH transport in HCEC","volume":"852","author":"Kannan","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.ejpb.2019.04.004_b0045","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2012.06.022","article-title":"Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation","volume":"164","author":"Gaillard","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.04.004_b0050","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3109\/1061186X.2014.888070","article-title":"Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood-brain barrier in rats","volume":"22","author":"Rip","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2019.04.004_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082331","article-title":"Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)","volume":"9","author":"Gaillard","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2019.04.004_b0060","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1021\/mp300272a","article-title":"Enhanced brain delivery of the opioid peptide DAMGO in glutathione pegylated liposomes: a microdialysis study","volume":"10","author":"Lindqvist","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2019.04.004_b0065","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2015.02.012","article-title":"Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease","volume":"203","author":"Rotman","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.04.004_b0070","doi-asserted-by":"crossref","unstructured":"C.C.M.J. Rip, F.M. Appeldoorn, R. Manca, J.M.R.V.K. Dorland, P.J. Gaillard, Receptor-mediated delivery of drugs across the blood\u2013brain barrier, in: Front. Pharmacol. Conference Abstract (2010): Pharmacology and Toxicology of the Blood\u2013brain Barrier: State of the Art, Needs for Future Research and Expected Benefits for the EU, 2010, https:\/\/doi.org\/10.3389\/conf.fphar.2010.02.00025.","DOI":"10.3389\/conf.fphar.2010.02.00025"},{"key":"10.1016\/j.ejpb.2019.04.004_b0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11095-015-1774-3","article-title":"In vivo functional evaluation of increased brain delivery of the opioid peptide DAMGO by glutathione-PEGylated liposomes","volume":"33","author":"Lindqvist","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.04.004_b0080","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.xphs.2017.03.009","article-title":"The impact of liposomal formulations on the release and brain delivery of methotrexate: an in vivo microdialysis study","volume":"106","author":"Hu","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.04.004_b0085","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1023\/A:1011992125204","article-title":"Methodological aspects of the use of a calibrator in in vivo microdialysis-further development of the retrodialysis method","volume":"15","author":"Bouw","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.04.004_b0090","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/dmd.105.007211","article-title":"Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p, u), and K(p, uu)","volume":"34","author":"Gupta","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejpb.2019.04.004_b0095","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s11095-007-9502-2","article-title":"On the rate and extent of drug delivery to the brain","volume":"25","author":"Hammarlund-Udenaes","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.04.004_b0100","series-title":"R: A Language and Environment for Statistical Computing","author":"Core Team","year":"2018"},{"key":"10.1016\/j.ejpb.2019.04.004_b0105","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/bimj.200810425","article-title":"Simultaneous inference in general parametric models","volume":"50","author":"Hothorn","year":"2008","journal-title":"Biom J"},{"key":"10.1016\/j.ejpb.2019.04.004_b0110","series-title":"Mutiple Comparisons using R","author":"Bretz","year":"2010"},{"key":"10.1016\/j.ejpb.2019.04.004_b0115","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1248\/bpb.b16-00462","article-title":"Topology of surface ligands on liposomes: characterization based on the terms, incorporation ratio, surface anchor density, and reaction yield","volume":"39","author":"Lee","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2019.04.004_b0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2014.10.024","article-title":"Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation","volume":"197","author":"Han","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2019.04.004_b0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejps.2016.07.003","article-title":"Pharmacokinetic considerations of nanodelivery to the brain: Using modeling and simulations to predict the outcome of liposomal formulations","volume":"92","author":"Lindqvist","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.04.004_b0130","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/jps.23994","article-title":"Enhanced doxorubicin delivery to the brain administered through glutathione PEGylated liposomal doxorubicin (2B3-101) as compared with generic Caelyx, ((R))\/Doxil((R))\u2013a cerebral open flow microperfusion pilot study","volume":"103","author":"Birngruber","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.04.004_b0135","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1172\/JCI106181","article-title":"Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlates","volume":"48","author":"Hryniuk","year":"1969","journal-title":"J. Clin. Invest."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118314413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118314413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T03:38:56Z","timestamp":1565149136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641118314413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":27,"alternative-id":["S0939641118314413"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.04.004","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted brain delivery of methotrexate by glutathione PEGylated liposomes: How can the formulation make a difference?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}